Medline Inc. is under investigation by Kaplan Fox & Kilsheimer LLP for potential securities violations following an FDA warning about significant manufacturing practice violations. The FDA highlighted failures in investigating batch discrepancies and microbial contamination, leading to a 7.16% drop in Medline's stock price. This is the second FDA action against Medline in two months, raising concerns about the company's compliance and quality controls. Investors who suffered losses or have information are encouraged to contact the law firm for potential legal action.
Medline Inc. and its recent regulatory issues are the subject, with Pluang's health sector data providing market context as of Sep 28, 2026 19:53 WIB. Among 100 priced health-sector US stocks tradable on Pluang, 23 rose and 64 fell today. Notable movers include Aurora Cannabis Inc (ACB) at USD 4.04 with a -1.46% change, BioNTech SE (BNTX) at USD 97.13 with a -1.41% change, and Enveric Biosciences Inc (ENVB) at USD 1.48 with a -1.33% change.
Remittix has raised $33 million and will burn 300 million RTX tokens, reducing supply by 20% ahead of public trading starting November 24, 2026. This token burn and near-cap funding boost scarcity and investor interest. Meanwhile, the XRP Ledger's No...
XTransfer, a leading global B2B cross-border payment platform, made its first appearance at Money20/20 USA 2026 in Las Vegas to accelerate its expansion into Latin American markets. The company recently completed regulatory registration in Chile, ena...
Kelvin Veras Real Estate completed 16 real estate transactions in its first year operating in New Jersey, including sales, purchases, rentals, and landlord services. This milestone highlights the company's successful market entry and diverse client s...
The documentary 'NURSE: Empathy Heals' premiered on October 21 in Nashville, showcasing personal stories of nurses and the critical role of empathy in healthcare. It highlights the emotional challenges nurses face, especially during crises like the C...
Oxford Square Capital Corp. announced it will hold a conference call on October 30, 2026, at 9:00 AM Eastern time to discuss its third quarter 2026 earnings. Investors can join the call via a toll-free number, and a recorded replay will be available ...
